Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma

HK Gan, DA Reardon, AB Lassman, R Merrell, Martin van den Bent, N Butowski, Z Lwin, H Wheeler, L Fichtel, AM Scott, EJ Gomez, J Fischer, H Mandich, H (Hong) Xiong, H J Lee, WP Munasinghe, LA Roberts-Rapp, PJ Ansell, KD Holen, P Kumthekar

Research output: Contribution to journalArticleAcademicpeer-review

60 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)838-847
Number of pages10
Issue number6
Publication statusPublished - 2018

Research programs

  • EMC OR-01

Cite this